Skip to content

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital Single-centre Prospective Randomised Interventional Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06512662
Acronym
PAKO-HDJ
Enrollment
60
Registered
2024-07-22
Start date
2024-10-08
Completion date
2027-03-31
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otorhinolaryngologic Neoplasms

Keywords

surgery, quality of life, anxiety, supportive care

Brief summary

Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term. Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract. Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.

Interventions

PROCEDUREConsultations with paramedics

Patients of experimental arm will beneficiate of supplemental consultations with paramedics intervenants at 1 month, 3 months and 6 months after surgery : * dietetician * speech therapist * psychologist * advanced practice nurse During these consultations, several scales will be performed to assess the patient's condition (anxiety, nutritional status, psychological condition, speech therapy status).

Sponsors

Clinique Pasteur Lanroze
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation * Understanding of spoken and written French * Patient covered by a social security scheme

Exclusion criteria

* Protected patient under a protective measure or legal safeguard * Pregnant or breast-feeding patients * Patients suffering from major cognitive disorders * Patients with major anxiety disorders prior to the onset of cancer

Design outcomes

Primary

MeasureTime frameDescription
Anxiety1 month ; 3 months ; 6 monthsAnxiety evaluation by State Trait Anxiety Inventory (STAI) scale. It is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Higher scores are positively correlated with higher levels of anxiety.

Secondary

MeasureTime frameDescription
Quality of life evaluation1 month ; 3 months ; 6 monthsQuality of life will be evaluated by EORTC C30. The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing the health-related quality of life (QoL) of cancer patients participating in international clinical trials.
pain evaluation1 month ; 3 months ; 6 monthsPain will be assessed using a visual analogue scale from 0 (no pain) to 10 (worst pain imaginable).
Toxic behaviour (tobacco and alcohol) evaluation1 month ; 3 months ; 6 monthsTobacco (number of cigarettes per day) and alcohol (number of units per day) consumption will be evaluated by questioning the patient.
Weight status evaluation1 month ; 3 months ; 6 monthsWeight statut will be determined by calculating the body mass index (BMI) and the percentage of loss weight.
nutritional status evaluation1 month ; 3 months ; 6 monthsNutritional status will be evaluated using SEFI (simple evaluation of food intake) scale. This scale is a Likert scale to assess the portion eaten at mealtimes, from 0 ("I haven't eaten anything") to 10 ('I have eaten everything").
swallowing assessment1 month ; 3 months ; 6 monthsSwallowing is measured by Deglutition Handicap Index (DHI). It is a questionnaire with 30 questions (10 physical, 10 functional, 10 emotional) with a Likert scale from "never" to "always".
vocal status assessment1 month ; 3 months ; 6 monthsVocal status is measured by Vocal Handicap Index (VHI). It is a questionnaire with 30 questions with a Likert scale from "never" to "always".

Countries

France

Contacts

CONTACTCamille Vuarin, APN
cvuarin@chp-brest.bzh+33 2 98 34 20 31

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026